Project description
A new vaccine for African swine fever
African swine fever (ASF) is a devastating infectious disease in pigs – usually deadly. No vaccine exists to combat this virus. The European Union has laid down prevention and control measures to be applied where African swine fever is suspected or confirmed, either in holdings or in wild boars. The EU-funded VACDIVA project will provide three safe and effective pilot vaccines for wild boar and domestic pigs that is ready for registration. It will also validate tests and develop cost-benefit and -effective surveillance and control-vaccination strategies. Field trials will be conducted in Kenya and Lithuania. Epidemiological modelling of worldwide scenarios will be offered in a portfolio of services to help animal health authorities control and eradicate the disease.
Objective
African Swine Fever (ASF) is one of the most important viral diseases affecting swine, with a serious socio-economic impact. It is present in more than 13 countries in Europe (10 in the EU), 28 sub-Saharan African countries, and 2 Asian countries, China and Mongolia. No vaccine is available and recent incursions in Europe and Asia are jeopardizing the pig industry worldwide. Control of ASF is based on early diagnosis and the implementation of strict sanitary measures. However, measures taken by affected countries have not been sufficient to stop spread.
The objective of VACDIVA is to solve the ASF problem in Europe and affected countries through innovation efforts. VACDIVA will provide (1) Three safe and effective pilot vaccines for wild boar and domestic pigs ready for registration; (2) validated companion DIVA tests and 3) cost-benefit and effective surveillance and control-vaccination strategies, with field trials in Lithuania and Kenia. Two world leader companies in vaccine production and ASF diagnostic kits will provide production of the new vaccines and DIVA tests. Epidemiological modelling of worldwide scenarios will be offered in a portfolio of services to help animal health authorities control and eradicate the disease. This project will provide policy makers valuable decision support tools to better prevent and control ASF.
VACDIVA counts with the expertise of two world ASF Reference Laboratories (OIE and FAO), the EU reference laboratory (EURL), six EU national Reference Laboratories (of 6 out of the 10 countries currently affected by ASF) and four prestigious ASF research institutions. Participation of Russian, Chinese and African laboratories will provide useful support, increasing acceptance of the vaccines. Active involvement of pig producers, agricultural associations and International agencies like FAO will enlarge the impact of communication, dissemination and training activities.
Fields of science
Keywords
Programme(s)
Funding Scheme
IA - Innovation actionCoordinator
28040 Madrid
Spain
See on map
Participants (22)
28006 Madrid
See on map
5831 AN Boxmeer
See on map
28037 MADRID
See on map
07100 Sassari
See on map
1024 Budapest
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
2462 Martonvasar
See on map
51006 Tartu
See on map
58605 Jihlava
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
LV-1076 Riga
See on map
08409 Vilnius
See on map
06126 Perugia
See on map
1300-477 Lisboa
See on map
80539 Munchen
See on map
6708 PB Wageningen
See on map
Participation ended
600901 VLADIMIR
See on map
100193 BEIJING
See on map
00100 Nairobi
See on map
266032 QINGDAO
See on map
1070 Bruxelles / Brussel
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
28003 Madrid
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28012 Madrid
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1143 Budapest
See on map